| Revolution Medicines, Inc. | 487K | US$100M | 21.4% |
| AtriCure, Inc. | 523K | US$29.4M | 6.3% |
| COMPASS Pathways Plc | 2.14M | US$26.6M | 5.7% |
| State Street SPDR S&P Biotech ETF | 152K | US$23.9M | 5.1% |
| Nektar Therapeutics | 323K | US$19.6M | 4.2% |
| IDEAYA Biosciences, Inc. | 439K | US$16.9M | 3.6% |
| Stereotaxis, Inc. | 13.7M | US$16.8M | 3.6% |
| Denali Therapeutics Inc. | 744K | US$15.4M | 3.3% |
| Arcus Biosciences, Inc. | 440K | US$11.4M | 2.4% |
| Cytokinetics, Incorporated | 172K | US$11.3M | 2.4% |
| Edgewise Therapeutics, Inc. | 222K | US$9.01M | 1.9% |
| Neurocrine Biosciences, Inc. | 62,716 | US$8.9M | 1.9% |
| Insulet Corporation | 67,870 | US$8.85M | 1.9% |
| Xenon Pharmaceuticals Inc. | 205K | US$7.62M | 1.6% |
| Axogen, Inc. | 180K | US$7.54M | 1.6% |
| DexCom, Inc. | 86,279 | US$7.45M | 1.6% |
| Syndax Pharmaceuticals, Inc. | 331K | US$6.23M | 1.3% |
| Larimar Therapeutics, Inc. | 1.89M | US$6.03M | 1.3% |
| Tandem Diabetes Care, Inc. | 355K | US$5.79M | 1.2% |
| Bicara Therapeutics Inc. | 300K | US$5.58M | 1.2% |
| Rapport Therapeutics, Inc. | 142K | US$4.77M | 1.0% |
| Immunovant, Inc. | 136K | US$4.58M | 0.98% |
| Inogen, Inc | 845K | US$4.45M | 0.95% |
| Neurogene Inc. | 151K | US$4.19M | 0.89% |
| Century Therapeutics, Inc. | 2.39M | US$4.08M | 0.87% |
| OrthoPediatrics Corp. | 179K | US$3.99M | 0.85% |
| Lakefront Biotherapeutics | 130K | US$3.86M | 0.82% |
| Stoke Therapeutics, Inc. | 146K | US$3.8M | 0.81% |
| Adlai Nortye Group Ltd. | 233K | US$3.72M | 0.80% |
| Eupraxia Pharmaceuticals, Inc. | 405K | US$3.68M | 0.79% |
| Celldex Therapeutics, Inc. | 108K | US$3.5M | 0.75% |
| Allogene Therapeutics, Inc. | 2M | US$3.2M | 0.68% |
| BioCryst Pharmaceuticals, Inc. | 380K | US$3.17M | 0.68% |
| Kymera Therapeutics, Inc. | 26,912 | US$3.01M | 0.64% |
| Aquestive Therapeutics, Inc. | 641K | US$2.97M | 0.63% |
| Atrium Therapeutics, Inc. | 300K | US$2.48M | 0.53% |
| iShares Biotechnology ETF | 11,595 | US$2.44M | 0.52% |
| PROCEPT BioRobotics Corporation | 120K | US$2.19M | 0.47% |
| Cybin, Inc. | 176K | US$2.16M | 0.46% |
| Align Technology, Inc. | 14,000 | US$2.03M | 0.43% |
| Viking Therapeutics, Inc. | 54,516 | US$1.78M | 0.38% |
| Maze Therapeutics, Inc. | 65,000 | US$1.77M | 0.38% |
| Alector, Inc. | 908K | US$1.68M | 0.36% |
| TELA Bio, Inc. | 1.44M | US$1.66M | 0.35% |
| MapLight Therapeutics, Inc. | 156K | US$1.59M | 0.34% |
| NervGen Pharma Corp. | 811K | US$1.55M | 0.33% |
| Structure Therapeutics, Inc. | 46,500 | US$1.45M | 0.31% |
| Profound Medical Corp | 225K | US$1.31M | 0.28% |
| Design Therapeutics, Inc. | 102K | US$1.28M | 0.27% |
| Lexeo Therapeutics, Inc. | 377K | US$1.27M | 0.27% |
| Inspire Medical Systems, Inc. | 18,200 | US$1.26M | 0.27% |
| CytomX Therapeutics, Inc. | 438K | US$1.19M | 0.25% |
| Fate Therapeutics, Inc. | 500K | US$1.19M | 0.25% |
| Mineralys Therapeutics, Inc. | 44,490 | US$1.12M | 0.24% |
| BridgeBio Oncology Therapeutics, Inc. | 266K | US$1.09M | 0.23% |
| Annexon, Inc. | 258K | US$1.09M | 0.23% |
| Biohaven Ltd. | 77,593 | US$1.04M | 0.22% |
| Q32 Bio Inc. | 98,500 | US$815K | 0.17% |
| Pyxis Oncology, Inc. | 345K | US$803K | 0.17% |
| ARS Pharmaceuticals, Inc. | 183K | US$788K | 0.17% |
| Ultragenyx Pharmaceutical Inc. | 51,100 | US$768K | 0.16% |
| Kura Oncology, Inc. | 69,068 | US$740K | 0.16% |
| BioNTech SE | 7,000 | US$688K | 0.15% |
| Adicet Bio, Inc. | 93,812 | US$670K | 0.14% |
| Seaport Therapeutics, Inc. | 32,400 | US$654K | 0.14% |
| Quoin Pharmaceuticals. Ltd | 132K | US$603K | 0.13% |
| Corbus Pharmaceuticals Holdings, Inc. | 83,248 | US$568K | 0.12% |
| Pliant Therapeutics, Inc. | 487K | US$526K | 0.11% |
| Editas Medicine, Inc. | 180K | US$464K | 0.10% |
| Accuray Incorporated | 1.68M | US$454K | 0.10% |
| Autolus Therapeutics plc | 179K | US$348K | 0.07% |
| Foghorn Therapeutics Inc. | 89,659 | US$320K | 0.07% |
| iBio, Inc. | 170K | US$201K | 0.04% |
| Tenaya Therapeutics, Inc. | 300K | US$181K | 0.04% |
| Kazia Therapeutics Ltd | 15,700 | US$151K | 0.03% |
| Verrica Pharmaceuticals Inc. | 23,750 | US$114K | 0.02% |
| Kardigan, Inc. | 5,000 | US$73,750 | 0.02% |
| Artiva Biotherapeutics, Inc. | 0 | US$0 | 0.00% |
| MBX Biosciences, Inc. | 0 | US$0 | 0.00% |
| Nuvectis Pharma, Inc. | 0 | US$0 | 0.00% |
| Orchestra BioMed Holdings, Inc. | 0 | US$0 | 0.00% |